Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


HANKOOK PHARM. CO., INC.

HANKOOK PHARM. CO., INC. Patent applications
Patent application numberTitlePublished
20110243970COMPOSITION FOR INHIBITION OF TRANSPLANT REJECTION CONTAINING THE CORDYCEPS MYCELLIA EXTRACT AS AN ACTIVE INGREDIENT - Disclosed is a composition for the inhibition of transplant rejection and the treatment of skin diseases, comprising a cordyceps mycellia extract as an active ingredient. The cordyceps mycellia extract significantly suppresses the production of antibodies to transplants without side effects, such as weight change. Based on natural material, the composition is non-toxic and harmless to the human body and thus can be used as an immunosuppressant for organ transplantation. Also, it stops oozing from sores and is useful in the treatment of skin diseases, including atopy, allergic reactions, decubitus ulcers, pemphigus and smallpox.10-06-2011
20100291154COMPOSITION FOR INHIBITION OF TRANSPLANT REJECTION CONTAINING THE CORDYCEPS MYCELLIA EXTRACT AS AN ACTIVE INGREDIENT - Disclosed is a composition for the inhibition of transplant rejection and the prevention and treatment of skin diseases, comprising a 11-18-2010
20100255024COMPOSITION FOR INHIBITION OF TRANSPLANT REJECTION CONTAINING THE PHELLINUS LINTEUS MYCELLIA EXTRACT AS AN ACTIVE INGREDIENT - Disclosed is a composition for the inhibition of transplant rejection and the prevention and treatment of skin diseases, comprising a 10-07-2010

Patent applications by HANKOOK PHARM. CO., INC.